Researchers have recently proven the worth of the Durham Erythema Test Device.
A British Journal of Dermatology paper† states that. "A recent comparison between the 'Durham' minimal erythema dose (MED) testing device and the older method found the Durham MED tester to be a convenient, safe and effective tool for determining patient MED values prior to narrow band UVB phototherapy." It goes on to state that. "These results show that the Durham MED tester gives very reproducible results. ... We conclude that the Durham MED test method is highly reproducible when used under carefully controlled lighting, using experienced observers."
Further details of the Durham Erythema Test Device are available in our Innovations section.
† Otman SG, Edwards C, Wyness K, Anstey AV. British Photodermatology Group: Summaries of Papers PD-7. Reproducibility of a semi-automated method of minimal erythema dose testing. British Journal of Dermatology (2005) 153 (Suppl. 1): 92-98.
11th August 2005
Click on the Innovation link at the side of any page to see our leading edge work.
Regional Medical Physics Department, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.
Tel: +44 (0)191-233-6161 E-mail: webmaster@rmpd.org.uk Web: http://www.rmpd.org.uk
By using this site you agree to our Terms and Conditions of Use. Please read our legal page.
Regional Medical Physics Department, a Clinical Directorate of the Newcastle upon Tyne Hospitals NHS Foundation Trust.
Copyright ©1999-2008 All Rights Reserved. Revised 7 November, 2008.
